Filters
Hikma to present at 42nd Annual J.P. Morgan Healthcare Conference
Press Release, Corporate
Hikma launches Phenylephrine HCl Injection, USP, in ready-to-use vials in the US
Press Release, Product
Hikma continues strong momentum across the Group and upgrades guidance for 2023
Press Release, Financial Results
Hikma and CanariaBio sign exclusive licensing agreement to bring Oregovomab to the Middle East and North Africa
Press Release, Product
Hikma launches Levocarnitine Injection, USP, in the US
Press Release, Product
Hikma marks two-year anniversary of KLOXXADO® launch by surpassing 375,000 doses donated in the US
Press Release, Product
Hikma and Cosmo partner on exclusive licensing agreement for Winlevi® (Clascoterone) for the Middle East and North Afric...
Press Release, Business Development
Hikma launches generic version of Vyvanse® following FDA approval
Press Release, Product
Hikma launches Vancomycin Hydrochloride for Injection, USP, in the US
Press Release, Product
Hikma and SK Biopharmaceuticals enter a strategic partnership for the Middle East and North Africa
Press Release, Business Development
Hikma remains a constituent of the FTSE4Good Index
Press Release, Responsibility
Hikma and Rakuten Medical sign exclusive licensing agreement for AlluminoxTM platform cancer treatment for the Middle Ea...
Press Release, Business Development
Hikma appoints new President of Injectables business
Press Release, Leadership
Hikma delivers strong H1 performance and raises Generics guidance
Press Release, Financial Results